{"name":"NX Development Corp","slug":"nx-development-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Gleolan","genericName":"Gleolan","slug":"gleolan","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Gleolan","genericName":"Gleolan","slug":"gleolan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOZmU0NEFST0NmNW5zS2tIbWlMSHlXX0hGRkI1d0UyRXZQVjNkZ1MtcWZibHRfSHVuWkxJWElTa3ppRFZuRjB6VGZ4a1YtZ2FRSUdQS0xyNkYtY3ZuenpjUVN0Z0JrZGRjVmRYWVR3WlQzY3NSeXJXaWI5ME9QVEJ6X1VwMG53ajZMbHE0MFFQb2VpMmFMVDJtZ0NEMFA3WXlsa01rRzZqWkJOZ1EzbFN0U1FCS0duUlY1dzI4WTNJN2I0TE8ycXhLcy1JLXJ1UlhFUDdmOGVuYXE4NXNUaWc?oc=5","date":"2026-04-07","type":"regulatory","source":"National Today","summary":"NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study - National Today","headline":"NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHNxeFlMbmszZFNqc29NZmhWTGZjZDJrZ0JMX0haTkpiSjlhUUJSZWt1d0llRU9WX01rYmVGdW04MEJXX2tDNXVYdUNULVhSbjlUNzRNMkdya0FSOUVQY0hJZ3llYzV2U2tqeThVZGJWdXJGLWM1MEpibWZYZF9BeVNMYjRRX2tGSUo1UGh4SW4tQQ?oc=5","date":"2026-01-16","type":"deal","source":"NPR","summary":"Trump struck deals with 16 drug companies. But they're still raising prices this year - NPR","headline":"Trump struck deals with 16 drug companies. But they're still raising prices this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWTFZSEFHRGhFdGxnVjR4cEFqRXoyQnVtV1lkeWlpTlhVNVFzWkpuTGRSZDA1YUFSc18wVXpmczBOOGV4RUZiZ2FaVkJEQl9XemFRVmlHbEMzbk1tMWZwUWM1Q2Q5Nmp4N1hfTDhXdDVhWUhlbHFfLXhDeFBoZEh6cS16clAwUFlFSGl0N0FXcGFHN2JuRjZyWmRFRTVVOUJmaUk5VHljRnlHT00?oc=5","date":"2025-06-16","type":"pipeline","source":"NPR","summary":"Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement - NPR","headline":"Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZGpES25IaEIxbkFHRVNsMEFtNzZOc21QMW80ZHV3cXZUMVFidzZSejJqdlpOR29OcDRVSk80LWZQY3REa2RYU2tzX1RwYVF1UGE0X0p1d2hPM1JTWW95TGQySmRLeW1xRTBzelRiVXNnemRvUEVud1JNeU56djlneWY2cFR5NEFDVk11cElmM0lhcWF4dm1uQ1g2dWNSb3c?oc=5","date":"2025-06-02","type":"pipeline","source":"Fierce Biotech","summary":"Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab - Fierce Biotech","headline":"Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9NM1psYmdlRkhERHV0ZWFIOEczeHdrcGtocEs2VXhkR285M0dZUkxfS0FMRnJHWlg5VlRMZ2tPd3BIMDZXWUxzNXl3aDE1SkZFNXZXWnQ3S29NU05mTG1IWFRDY1RhTEJrVm5sdlhIQ0hDM1U0V3NTdw?oc=5","date":"2025-05-22","type":"deal","source":"nipponexpress-holdings.com","summary":"NX China acquires GDP certification for Shanghai and Lianyungang facilities - nipponexpress-holdings.com","headline":"NX China acquires GDP certification for Shanghai and Lianyungang facilities - nipponexpress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPaTczMTdmbTBoLUUwZ2lhczhEU0E1M0l3bWt3RUpicG1lYl9ETy1WQ0FRY3FuSVNTdXBBTS10d1NZdnMxT1FhOXNnSU12RklTQlA2NVpKdlhwekRuSS1aZlg4U21QWHQ5b2didC00Q3VUU2NKWkNBQ2p2WUZGZDE2RjA3QjdJQ2VVd0tFM0FETnlQN3ZuMTFiTjJOTQ?oc=5","date":"2025-05-12","type":"pipeline","source":"NPR","summary":"Trump signs an order to reduce drug prices, but it's unclear how it would work - NPR","headline":"Trump signs an order to reduce drug prices, but it's unclear how it would work","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"PR Newswire","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOMXZOTDZEVXJ3UWxmSVBzMXgyUHBydUVVUFJ4bEtnNjdtLUMyblpsMzVrTkpnVno5azBYaXYxY3JycjhDWkdLMWt5ZGhmaGd2ckpQbDN2NlNHYlhHQVRPb1JRYTJaZlRCQkVWLUtvczlsVVEwQ2lXYUxhd1NlQXJpSHQ5Ymlhd0d1d0lWellIcFVTR1NtRVBxcDNwQmk1OGNHR0k5X292NzhDdGdYV2ItU2p2c0x0UElRMVYzSTBRdk9PN2VCTUdyWFFPM0hneTBrOUhDR3kwdjZid0poZXhVMw?oc=5","date":"2022-06-13","type":"pipeline","source":"BioPharma APAC","summary":"Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry - BioPharma APAC","headline":"Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPTjZTWUpxSjlLWFhGXzVRRUVxMGhCZk9uMllLZHpXQl9zWnJSdnFHXzZxSm16WEl0T09xSTdaaXpKelFyNlZyaFpUZDJHZDh4eE0zalo3S1QtVTdiMlpCcC1YeW9Fa2d3MnVRUzdFS1lUcVU3Nk0yVnoxUWZ6bHdUdFRR?oc=5","date":"2022-03-02","type":"pipeline","source":"Yahoo Finance","summary":"NX Development Corp. (NXDC) Names Salvatore DeSena, M.D., as Chief Executive Officer - Yahoo Finance","headline":"NX Development Corp. (NXDC) Names Salvatore DeSena, M.D., as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNa0d5SmppSnFFYWk1QUFkSDdSZkRLSWNCaUY5V2IyT1RPX3A1M3ZQOHNxWUthbVJoc2pwWGJ0R2hPVEdSVlAyTEhHa3F6U3VTcGNUZUNScllGZzg5Q2FDVXVqREpDTUVYRnZOclhZcWNZbld2YXNBRlJFSHRLX3NHRjNySzF1a0VaQUtnenFrRFZsUE15WkJ6Zi04eF9WNjJWYmQ1cFV4VVVGN3B4X0Q1eF9wRnJ1S2ROclp5Ym1wUkdfT28taWt2S2F5M3U0UnBvQmdndEk3ZVVSbDlHazNqeVFHcGRBNXc5bXE2cXlUd1BTSFRNS0xRQ2NMMXJLNDV6T3JTb3VRaw?oc=5","date":"2021-04-15","type":"pipeline","source":"globenewswire.com","summary":"T.J. Stalvey Joins NX Development Corp. (NXDC) as Vice President of Clinical Development and Medical Affairs - globenewswire.com","headline":"T.J. Stalvey Joins NX Development Corp. (NXDC) as Vice President of Clinical Development and Medical Affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPaGpIcjJXWHluaVJyU1E3ZnpHamtHcGpjV1JfLU92TG1tbDRHem1SR3FKb3owY2ZzNklYa29GY19QZUJ6TVYtNm1VRG1rZG1HbWxiVWh4QnpfR0xoRm1yUEVRUWxOWTRaencxSXEzTncybXVqV21VWDBfRFJrLThYYlY3WlZqSlNtS3lYWHJ1cU1qX0tBS1lKVzBiZk5JQnZ5?oc=5","date":"2020-05-15","type":"pipeline","source":"Fox Chase Cancer Center","summary":"Beijing Top Grade Medical Equipment Company and SBI Pharmaceuticals Co., Ltd. - Fox Chase Cancer Center","headline":"Beijing Top Grade Medical Equipment Company and SBI Pharmaceuticals Co., Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxOdmVfbTl4aVdFNXA4MW83VWRXaVJjY1YybUpURGdHMkpXdjdLMmdIczlLYkRZTEpnSHpsU2c1Nm84MS1Xell2emVqd1RFc3d3eVFRblpWNzg3eC1taG5ybkVJTTBiTmsteDBUZHRsTzVlVEU1bzYxYjVWTEZSVXBRT001T0RvX3NJU2NBXzZ4eWF6UVFDc21TcnpMSXdFLWxVYkVTejl4YmFTVlZZYzVfcnE3UWkxV3dVSi1fQnN2UkYwbGZpZUZvcE5uNGNCbV9CYXQwaTJKWE9fdlVEMEo1QW5XSzRkUVJ4Zi14TWJsTFNESXlMSkFPNmQwblB0ZnhxdjlGVDNTVWdVM1QwNGVNSm1wVmxaMWMxU25aOEQ1MUZ5cTRxN0Rra1Q3TDVRWEJGUmcwclJfd180UktDWWhFcURQTjdhQQ?oc=5","date":"2018-10-03","type":"regulatory","source":"globenewswire.com","summary":"NX Development Corp. (NXDC) Launches FDA-Approved Gleolan™ - globenewswire.com","headline":"NX Development Corp. (NXDC) Launches FDA-Approved Gleolan™","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}